|
|
Deubiquitinases as pivotal regulators of T cell functions |
Xiao-Dong Yang1, Shao-Cong Sun2,3() |
1. Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 2. Department of Immunology, The University of Texas MD Anderson Cancer Center, 7455 Fannin Street, Box 902, Houston, TX 77030, USA 3. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA |
|
|
Abstract T cells efficiently respond to foreign antigens to mediate immune responses against infections but are tolerant to self-tissues. Defect in T cell activation is associated with severe immune deficiencies, whereas aberrant T cell activation contributes to the pathogenesis of diverse autoimmune and inflammatory diseases. An emerging mechanism that regulates T cell activation and tolerance is ubiquitination, a reversible process of protein modification that is counter-regulated by ubiquitinating enzymes and deubiquitinases (DUBs). DUBs are isopeptidases that cleave polyubiquitin chains and remove ubiquitin from target proteins, thereby controlling the magnitude and duration of ubiquitin signaling. It is now well recognized that DUBs are crucial regulators of T cell responses and serve as potential therapeutic targets for manipulating immune responses in the treatment of immunological disorders and cancer. This review will discuss the recent progresses regarding the functions of DUBs in T cells.
|
Keywords
deubiquitinase
ubiquitination
T cell activation
T cell differentiation
T cell tolerance
|
Corresponding Author(s):
Shao-Cong Sun
|
Just Accepted Date: 02 July 2018
Online First Date: 30 July 2018
Issue Date: 03 September 2018
|
|
1 |
Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009; 27(1): 591–619
https://doi.org/10.1146/annurev.immunol.021908.132706
pmid: 19132916
|
2 |
Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28(1): 445–489
https://doi.org/10.1146/annurev-immunol-030409-101212
pmid: 20192806
|
3 |
Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005; 435(7042): 590–597
https://doi.org/10.1038/nature03724
pmid: 15931211
|
4 |
Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 2012; 4(6): a006957
https://doi.org/10.1101/cshperspect.a006957
pmid: 22661634
|
5 |
O’Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010; 327(5969): 1098–1102
https://doi.org/10.1126/science.1178334
pmid: 20185720
|
6 |
Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity 2014; 41(4): 529–542
https://doi.org/10.1016/j.immuni.2014.10.004
pmid: 25367570
|
7 |
Damsker JM, Hansen AM, Caspi RR. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 2010; 1183(1): 211–221
https://doi.org/10.1111/j.1749-6632.2009.05133.x
pmid: 20146717
|
8 |
Zhang N, Bevan MJ. CD8+ T cells: foot soldiers of the immune system. Immunity 2011; 35(2): 161–168
https://doi.org/10.1016/j.immuni.2011.07.010
pmid: 21867926
|
9 |
Halle S, Halle O, Förster R. Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo. Trends Immunol 2017; 38(6): 432–443
https://doi.org/10.1016/j.it.2017.04.002
pmid: 28499492
|
10 |
Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9(1): 271–296
https://doi.org/10.1146/annurev.iy.09.040191.001415
pmid: 1910679
|
11 |
Kennedy R, Celis E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev 2008; 222(1): 129–144
https://doi.org/10.1111/j.1600-065X.2008.00616.x
pmid: 18363998
|
12 |
Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009; 228(1): 9–22
https://doi.org/10.1111/j.1600-065X.2008.00745.x
pmid: 19290918
|
13 |
Ohashi PS. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol 2002; 2(6): 427–438
https://doi.org/10.1038/nri822
pmid: 12093009
|
14 |
Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67(1): 425–479
https://doi.org/10.1146/annurev.biochem.67.1.425
pmid: 9759494
|
15 |
Kulathu Y, Komander D. Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012; 13(8): 508–523
https://doi.org/10.1038/nrm3394
pmid: 22820888
|
16 |
Akutsu M, Dikic I, Bremm A. Ubiquitin chain diversity at a glance. J Cell Sci 2016; 129(5): 875–880
https://doi.org/10.1242/jcs.183954
pmid: 26906419
|
17 |
Ikeda F. Linear ubiquitination signals in adaptive immune responses. Immunol Rev 2015; 266(1): 222–236
https://doi.org/10.1111/imr.12300
pmid: 26085218
|
18 |
Chen J, Chen ZJ. Regulation of NF-kB by ubiquitination. Curr Opin Immunol 2013; 25(1): 4–12
https://doi.org/10.1016/j.coi.2012.12.005
pmid: 23312890
|
19 |
Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123(5): 773–786
https://doi.org/10.1016/j.cell.2005.11.007
pmid: 16325574
|
20 |
Abdul Rehman SA, Kristariyanto YA, Choi SY, Nkosi PJ, Weidlich S, Labib K, Hofmann K, Kulathu Y. MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol Cell 2016; 63(1): 146–155
https://doi.org/10.1016/j.molcel.2016.05.009
pmid: 27292798
|
21 |
Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem 2017; 86(1): 159–192
https://doi.org/10.1146/annurev-biochem-061516-044916
pmid: 28498721
|
22 |
Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol 2002; 2(5): 309–322
https://doi.org/10.1038/nri798
pmid: 12033737
|
23 |
Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 2014; 14(6): 377–391
https://doi.org/10.1038/nri3667
pmid: 24830344
|
24 |
Hu H, Sun SC. Ubiquitin signaling in immune responses. Cell Res 2016; 26(4): 457–483
https://doi.org/10.1038/cr.2016.40
pmid: 27012466
|
25 |
Reiley WW, Zhang M, Jin W, Losiewicz M, Donohue KB, Norbury CC, Sun SC. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol 2006; 7(4): 411–417
https://doi.org/10.1038/ni1315
pmid: 16501569
|
26 |
Sun SC. CYLD: a tumor suppressor deubiquitinase regulating NF-kB activation. Cell Death Differ 2010; 17(1): 25–34 doi:10.1038/cdd.2009.43
pmid: 19373246
|
27 |
Tsagaratou A, Trompouki E, Grammenoudi S, Kontoyiannis DL, Mosialos G. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kB essential modulator-dependent manner. J Immunol 2010; 185(4): 2032–2043
https://doi.org/10.4049/jimmunol.0903919
pmid: 20644164
|
28 |
Reissig S, Hövelmeyer N, Tang Y, Weih D, Nikolaev A, Riemann M, Weih F, Waisman A. The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells. Immunol Cell Biol 2015; 93(6): 558–566
https://doi.org/10.1038/icb.2014.122
pmid: 25601276
|
29 |
Lee AJ, Zhou X, Chang M, Hunzeker J, Bonneau RH, Zhou D, Sun SC. Regulation of natural killer T-cell development by deubiquitinase CYLD. EMBO J 2010; 29(9): 1600–1612
https://doi.org/10.1038/emboj.2010.31
pmid: 20224552
|
30 |
Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25(1): 297–336
https://doi.org/10.1146/annurev.immunol.25.022106.141711
pmid: 17150027
|
31 |
Crosby CM, Kronenberg M. Invariant natural killer T cells: front line fighters in the war against pathogenic microbes. Immunogenetics 2016; 68(8): 639–648
https://doi.org/10.1007/s00251-016-0933-y
pmid: 27368411
|
32 |
Dashtsoodol N, Shigeura T, Aihara M, Ozawa R, Kojo S, Harada M, Endo TA, Watanabe T, Ohara O, Taniguchi M. Alternative pathway for the development of Va14+ NKT cells directly from CD4−CD8− thymocytes that bypasses the CD4+CD8+ stage. Nat Immunol 2017; 18(3): 274–282
https://doi.org/10.1038/ni.3668
pmid: 28135253
|
33 |
Drennan MB, Govindarajan S, Verheugen E, Coquet JM, Staal J, McGuire C, Taghon T, Leclercq G, Beyaert R, van Loo G, Lambrecht BN, Elewaut D. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med 2016; 213(10): 1973–1981
https://doi.org/10.1084/jem.20151065
pmid: 27551157
|
34 |
Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 2013; 14(11): 1146–1154
https://doi.org/10.1038/ni.2731
pmid: 24097110
|
35 |
Dufner A, Kisser A, Niendorf S, Basters A, Reissig S, Schönle A, Aichem A, Kurz T, Schlosser A, Yablonski D, Groettrup M, Buch T, Waisman A, Schamel WW, Prinz M, Knobeloch KP. The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells. Nat Immunol 2015; 16(9): 950–960
https://doi.org/10.1038/ni.3230
pmid: 26214742
|
36 |
Adoro S, Park KH, Bettigole SE, Lis R, Shin HR, Seo H, Kim JH, Knobeloch KP, Shim JH, Glimcher LH. Post-translational control of T cell development by the ESCRT protein CHMP5. Nat Immunol 2017; 18(7): 780–790
https://doi.org/10.1038/ni.3764
pmid: 28553951
|
37 |
Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol Rev 2012; 246(1): 95–106
https://doi.org/10.1111/j.1600-065X.2012.01108.x
pmid: 22435549
|
38 |
Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, Autenrieth I, Bohn E, Sakurai H, Niedenthal R, Resch K, Kracht M. The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep 2006; 7(8): 838–844
pmid: 16845370
|
39 |
Reiley WW, Jin W, Lee AJ, Wright A, Wu X, Tewalt EF, Leonard TO, Norbury CC, Fitzpatrick L, Zhang M, Sun SC. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 2007; 204(6): 1475–1485
https://doi.org/10.1084/jem.20062694
pmid: 17548520
|
40 |
Schmid U, Stenzel W, Koschel J, Raptaki M, Wang X, Naumann M, Matuschewski K, Schlüter D, Nishanth G. The deubiquitinating enzyme cylindromatosis dampens CD8+ T cell responses and is a critical factor for experimental cerebral malaria and blood-brain barrier damage. Front Immunol 2017; 8: 27
https://doi.org/10.3389/fimmu.2017.00027
pmid: 28203236
|
41 |
Liu X, Li H, Zhong B, Blonska M, Gorjestani S, Yan M, Tian Q, Zhang DE, Lin X, Dong C. USP18 inhibits NF-kB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. J Exp Med 2013; 210(8): 1575–1590
https://doi.org/10.1084/jem.20122327
pmid: 23825189
|
42 |
Harhaj EW, Dixit VM. Deubiquitinases in the regulation of NF-kB signaling. Cell Res 2011; 21(1): 22–39
https://doi.org/10.1038/cr.2010.166
pmid: 21119682
|
43 |
Giordano M, Roncagalli R, Bourdely P, Chasson L, Buferne M, Yamasaki S, Beyaert R, van Loo G, Auphan-Anezin N, Schmitt-Verhulst AM, Verdeil G. The tumor necrosis factor α-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc Natl Acad Sci USA 2014; 111(30): 11115–11120
https://doi.org/10.1073/pnas.1406259111
pmid: 25024217
|
44 |
Just S, Nishanth G, Buchbinder JH, Wang X, Naumann M, Lavrik I, Schlüter D. A20 curtails primary but augments secondary CD8+ T cell responses in intracellular bacterial infection. Sci Rep 2016; 6(1): 39796
https://doi.org/10.1038/srep39796
pmid: 28004776
|
45 |
Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol 2015; 16(6): 618–627
https://doi.org/10.1038/ni.3172
pmid: 25939025
|
46 |
Matsuzawa Y, Oshima S, Takahara M, Maeyashiki C, Nemoto Y, Kobayashi M, Nibe Y, Nozaki K, Nagaishi T, Okamoto R, Tsuchiya K, Nakamura T, Ma A, Watanabe M. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy. Autophagy 2015; 11(7): 1052–1062
https://doi.org/10.1080/15548627.2015.1055439
pmid: 26043155
|
47 |
Linares JF, Duran A, Yajima T, Pasparakis M, Moscat J, Diaz-Meco MT. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell 2013; 51(3): 283–296
https://doi.org/10.1016/j.molcel.2013.06.020
pmid: 23911927
|
48 |
Park Y, Jin HS, Liu YC. Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex. Proc Natl Acad Sci USA 2013; 110(23): 9433–9438
https://doi.org/10.1073/pnas.1221925110
pmid: 23690623
|
49 |
Zou Q, Jin J, Hu H, Li HS, Romano S, Xiao Y, Nakaya M, Zhou X, Cheng X, Yang P, Lozano G, Zhu C, Watowich SS, Ullrich SE, Sun SC. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol 2014; 15(6): 562–570
https://doi.org/10.1038/ni.2885
pmid: 24777531
|
50 |
Hu H, Wang H, Xiao Y, Jin J, Chang JH, Zou Q, Xie X, Cheng X, Sun SC. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med 2016; 213(3): 399–414
https://doi.org/10.1084/jem.20151426
pmid: 26903241
|
51 |
Carpino N, Chen Y, Nassar N, Oh HW. The Sts proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways. Mol Immunol 2009; 46(16): 3224–3231
https://doi.org/10.1016/j.molimm.2009.08.015
pmid: 19733910
|
52 |
Yang M, Chen T, Li X, Yu Z, Tang S, Wang C, Gu Y, Liu Y, Xu S, Li W, Zhang X, Wang J, Cao X. K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8+ T cell activation. Nat Immunol 2015; 16(12): 1253–1262
https://doi.org/10.1038/ni.3258
pmid: 26390156
|
53 |
Naik E, Webster JD, DeVoss J, Liu J, Suriben R, Dixit VM. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med 2014; 211(10): 1947–1955
https://doi.org/10.1084/jem.20140860
pmid: 25200027
|
54 |
Naik E, Dixit VM. Usp9X is required for lymphocyte activation and homeostasis through its control of ZAP70 ubiquitination and PKCb kinase activity. J Immunol 2016; 196(8): 3438–3451
https://doi.org/10.4049/jimmunol.1403165
pmid: 26936881
|
55 |
Garreau A, Blaize G, Argenty J, Rouquié N, Tourdès A, Wood SA, Saoudi A, Lesourne R. Grb2-mediated recruitment of USP9X to LAT enhances themis stability following thymic selection. J Immunol 2017; 199(8): 2758–2766
https://doi.org/10.4049/jimmunol.1700566
pmid: 28877990
|
56 |
Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4+ T cells toward distinct T-helper cell subsets. Immunol Rev 2013; 252(1): 12–23 PMID:23405892
https://doi.org/10.1111/imr.12032
|
57 |
Tu E, Chia CPZ, Chen W, Zhang D, Park SA, Jin W, Wang D, Alegre ML, Zhang YE, Sun L, Chen W. T Cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation. Immunity2018; 48(4): 745–759e6
|
58 |
Walsh KP, Mills KH. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol 2013; 34(11): 521–530
https://doi.org/10.1016/j.it.2013.07.006
pmid: 23973621
|
59 |
Berenson LS, Ota N, Murphy KM. Issues in T-helper 1 development—resolved and unresolved. Immunol Rev 2004; 202(1): 157–174
https://doi.org/10.1111/j.0105-2896.2004.00208.x
pmid: 15546392
|
60 |
Pan L, Chen Z, Wang L, Chen C, Li D, Wan H, Li B, Shi G. Deubiquitination and stabilization of T-bet by USP10. Biochem Biophys Res Commun 2014; 449(3): 289–294
https://doi.org/10.1016/j.bbrc.2014.05.037
pmid: 24845384
|
61 |
Rutz S, Kayagaki N, Phung QT, Eidenschenk C, Noubade R, Wang X, Lesch J, Lu R, Newton K, Huang OW, Cochran AG, Vasser M, Fauber BP, DeVoss J, Webster J, Diehl L, Modrusan Z, Kirkpatrick DS, Lill JR, Ouyang W, Dixit VM. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 2015; 518(7539): 417–421
https://doi.org/10.1038/nature13979
pmid: 25470037
|
62 |
Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O’Rourke KM, Eby M, Pietras E, Cheng G, Bazan JF, Zhang Z, Arnott D, Dixit VM. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007; 318(5856): 1628–1632
https://doi.org/10.1126/science.1145918
pmid: 17991829
|
63 |
Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, Zhang J, Xing Y, Chen Z, Tsun A, Li D, Piccioni M, Zhang Y, Guo Q, Jiang L, Bao L, Lv L, Li B. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor gt (RORgt) in Th17 cells. J Biol Chem 2014; 289(37): 25546–25555
https://doi.org/10.1074/jbc.M114.565291
pmid: 25070893
|
64 |
Yang J, Xu P, Han L, Guo Z, Wang X, Chen Z, Nie J, Yin S, Piccioni M, Tsun A, Lv L, Ge S, Li B. Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORgt. J Immunol 2015; 194(9): 4094–4097
https://doi.org/10.4049/jimmunol.1401451
pmid: 25821221
|
65 |
He Z, Wang F, Ma J, Sen S, Zhang J, Gwack Y, Zhou Y, Sun Z. Ubiquitination of RORgt at lysine 446 limits Th17 differentiation by controlling coactivator recruitment. J Immunol 2016; 197(4): 1148–1158
https://doi.org/10.4049/jimmunol.1600548
pmid: 27430721
|
66 |
Zou Q, Jin J, Xiao Y, Zhou X, Hu H, Cheng X, Kazimi N, Ullrich SE, Sun SC. T cell intrinsic USP15 deficiency promotes excessive IFN-g production and an immunosuppressive tumor microenvironment in MCA-induced fibrosarcoma. Cell Reports 2015; 13(11): 2470–2479
https://doi.org/10.1016/j.celrep.2015.11.046
pmid: 26686633
|
67 |
Jin J, Xie X, Xiao Y, Hu H, Zou Q, Cheng X, Sun SC. Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid. Nat Immunol 2016; 17(3): 259–268
https://doi.org/10.1038/ni.3347
pmid: 26808229
|
68 |
Kool M, van Loo G, Waelput W, De Prijck S, Muskens F, Sze M, van Praet J, Branco-Madeira F, Janssens S, Reizis B, Elewaut D, Beyaert R, Hammad H, Lambrecht BN. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 2011; 35(1): 82–96
https://doi.org/10.1016/j.immuni.2011.05.013
pmid: 21723156
|
69 |
Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R, Oshima S, Barrera J, Huang EJ, Hou B, Malynn BA, Reizis B, DeFranco A, Criswell LA, Nakamura MC, Ma A. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 2011; 12(12): 1184–1193
https://doi.org/10.1038/ni.2135
pmid: 22019834
|
70 |
Liang J, Huang HI, Benzatti FP, Karlsson AB, Zhang JJ, Youssef N, Ma A, Hale LP, Hammer GE. Inflammatory Th1 and Th17 in the intestine are each driven by functionally specialized dendritic cells with distinct requirements for MyD88. Cell Reports 2016; 17(5): 1330–1343
https://doi.org/10.1016/j.celrep.2016.09.091
pmid: 27783947
|
71 |
Wang L, Hong B, Jiang X, Jones L, Chen SY, Huang XF. A20 controls macrophage to elicit potent cytotoxic CD4+ T cell response. PLoS One 2012; 7(11): e48930
https://doi.org/10.1371/journal.pone.0048930
pmid: 23145026
|
72 |
Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133(5): 775–787
https://doi.org/10.1016/j.cell.2008.05.009
pmid: 18510923
|
73 |
Lee AJ, Wu X, Cheng H, Zhou X, Cheng X, Sun SC. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling. J Biol Chem 2010; 285(21): 15696–15703
https://doi.org/10.1074/jbc.M109.095190
pmid: 20233721
|
74 |
Oh H, Ghosh S. NF-kB: roles and regulation in different CD4+ T-cell subsets. Immunol Rev 2013; 252(1): 41–51
https://doi.org/10.1111/imr.12033
pmid: 23405894
|
75 |
Zhao Y, Thornton AM, Kinney MC, Ma CA, Spinner JJ, Fuss IJ, Shevach EM, Jain A. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor b (TGF-b) signaling and the development of regulatory T cells. J Biol Chem 2011; 286(47): 40520–40530
https://doi.org/10.1074/jbc.M111.292961
pmid: 21931165
|
76 |
Reissig S, Hövelmeyer N, Weigmann B, Nikolaev A, Kalt B, Wunderlich TF, Hahn M, Neurath MF, Waisman A. The tumor suppressor CYLD controls the function of murine regulatory T cells. J Immunol 2012; 189(10): 4770–4776
https://doi.org/10.4049/jimmunol.1201993
pmid: 23066153
|
77 |
Fischer JC, Otten V, Kober M, Drees C, Rosenbaum M, Schmickl M, Heidegger S, Beyaert R, van Loo G, Li XC, Peschel C, Schmidt-Supprian M, Haas T, Spoerl S, Poeck H. A20 restrains thymic regulatory T cell development. J Immunol 2017; 199(7): 2356–2365
https://doi.org/10.4049/jimmunol.1602102
pmid: 28842469
|
78 |
Chang JH, Xiao Y, Hu H, Jin J, Yu J, Zhou X, Wu X, Johnson HM, Akira S, Pasparakis M, Cheng X, Sun SC. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol 2012; 13(5): 481–490
https://doi.org/10.1038/ni.2267
pmid: 22484734
|
79 |
van Loosdregt J, Coffer PJ. Post-translational modification networks regulating FOXP3 function. Trends Immunol 2014; 35(8): 368–378
https://doi.org/10.1016/j.it.2014.06.005
pmid: 25047417
|
80 |
van Loosdregt J, Fleskens V, Fu J, Brenkman AB, Bekker CP, Pals CE, Meerding J, Berkers CR, Barbi J, Gröne A, Sijts AJ, Maurice MM, Kalkhoven E, Prakken BJ, Ovaa H, Pan F, Zaiss DM, Coffer PJ. Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity 2013; 39(2): 259–271
https://doi.org/10.1016/j.immuni.2013.05.018
pmid: 23973222
|
81 |
Wang L, Kumar S, Dahiya S, Wang F, Wu J, Newick K, Han R, Samanta A, Beier UH, Akimova T, Bhatti TR, Nicholson B, Kodrasov MP, Agarwal S, Sterner DE, Gu W, Weinstock J, Butt TR, Albelda SM, Hancock WW. Ubiquitin-specific protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity. EBioMedicine 2016; 13: 99–112
https://doi.org/10.1016/j.ebiom.2016.10.018
pmid: 27769803
|
82 |
Xiao Y, Nagai Y, Deng G, Ohtani T, Zhu Z, Zhou Z, Zhang H, Ji MQ, Lough JW, Samanta A, Hancock WW, Greene MI. Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60. Cell Reports 2014; 7(5): 1471–1480
https://doi.org/10.1016/j.celrep.2014.04.021
pmid: 24835996
|
83 |
Turnbull AP, Ioannidis S, Krajewski WW, Pinto-Fernandez A, Heride C, Martin ACL, Tonkin LM, Townsend EC, Buker SM, Lancia DR, Caravella JA, Toms AV, Charlton TM, Lahdenranta J, Wilker E, Follows BC, Evans NJ, Stead L, Alli C, Zarayskiy VV, Talbot AC, Buckmelter AJ, Wang M, McKinnon CL, Saab F, McGouran JF, Century H, Gersch M, Pittman MS, Marshall CG, Raynham TM, Simcox M, Stewart LMD, McLoughlin SB, Escobedo JA, Bair KW, Dinsmore CJ, Hammonds TR, Kim S, Urbé S, Clague MJ, Kessler BM, Komander D. Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature 2017; 550(7677): 481–486
https://doi.org/10.1038/nature24451
pmid: 29045389
|
84 |
Kategaya L, Di Lello P, Rougé L, Pastor R, Clark KR, Drummond J, Kleinheinz T, Lin E, Upton JP, Prakash S, Heideker J, McCleland M, Ritorto MS, Alessi DR, Trost M, Bainbridge TW, Kwok MCM, Ma TP, Stiffler Z, Brasher B, Tang Y, Jaishankar P, Hearn BR, Renslo AR, Arkin MR, Cohen F, Yu K, Peale F, Gnad F, Chang MT, Klijn C, Blackwood E, Martin SE, Forrest WF, Ernst JA, Ndubaku C, Wang X, Beresini MH, Tsui V, Schwerdtfeger C, Blake RA, Murray J, Maurer T, Wertz IE. USP7 small-molecule inhibitors interfere with ubiquitin binding. Nature 2017; 550(7677): 534–538
https://doi.org/10.1038/nature24006
pmid: 29045385
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|